RadioGel

In a significant advancement for cancer therapy, the Food and Drug Administration (FDA) has awarded RadioGel Precision Radionuclide Therapy the coveted Breakthrough Device Designation. Developed by Vivos Inc. (OTCQB: RDGL), this designation marks a crucial milestone in the treatment of solid...